Recent innovations and advancements in 3-dimensional (3D) echocardiography allow for better understanding of anatomic relationships and improve communication with the interventional cardiologist for guidance of catheter-based interventions. The mitral valve lends itself best for imaging with transesophageal echocardiography (TEE). Consequently, the role of 3D TEE in guiding catheter-based mitral interventions has been evolving rapidly. Although several publications have reported on the advantages and role of 3D TEE in guiding one or more of the steps involved in percutaneous mitral valve repair using the MitraClip, none offer a comprehensive and practical user-friendly guide. This review article provides the reader with practical intraprocedural tips on use of 3D TEE to guide all relevant steps involved in the procedure including how to acquire the images needed and what
P
ercutaneous edge-to-edge mitral valve (MV) repair using the MitraClip system (Abbott) is used to treat highrisk patients with severe symptomatic functional or degenerative mitral regurgitation (MR) by approximation of the free edges of the leaflet at the site of regurgitation creating a double-orifice MV. 1 Initial application of this technique was limited to patients with predominantly central MR, originating from the A2/P2 scallops of the MV. More recently, this technique has been successfully applied to noncentral (paracentral and paracommissural) regurgitation due to degenerative MV disease with frequent creation of a single smaller MV orifice. 2 In October 2013, the US Food and Drug Administration approved MitraClip for treatment of patients with severe degenerative MR considered to have prohibitive surgical risk. 3 Two-dimensional (2D) transesophageal echocardiography (TEE) plays a pivotal role in patient selection, procedural guidance, and assessing the results. Three-dimensional (3D) TEE offers additional benefits of realtime enface imaging of the MV and adjoining structures that provides contextual anatomic guidance during transcatheter interventions. 4 It has been found to be superior to 2D TEE in guiding many of the steps involved in percutaneous MV repair (PMVR), 2, 5, 6 particularly when the MR is not central. 7 This article provides a practical "step-by-step" periprocedural guide to use of 3D TEE (Philips Medical Systems) in patients undergoing PMVR (Table) .
PREPROCEDURAL PLANNING
A distinct advantage of 3D TEE over conventional 2D TEE is the ability to visualize the entire MV and surrounding structures from a single transducer position and in real time with minimal or no probe manipulation. The images obtained reliably reflect actual anatomy in a format readily appreciated by nonimaging cardiologists. 4 In
For editorial comment, see page 4. addition to delineating the MV anatomy and assessing the mechanism of regurgitation, an important objective of 3D TEE during the preprocedural phase of PMVR is to perform an imaging "dry run" in preparation for the actual procedure. This step serves the purpose of choosing the most appropriate image planes to guide the various steps of the procedure including optimal views for perpendicular orientation of the MitraClip arms to the site of leaflet malcoaptation.
Because clip placement is not advisable if the MV area (MVA) is under 4 cm 2 , accurate measurement of MVA is a prerequisite. A major limitation of 2D-derived planimetry of MVA is correct image plane orientation. By providing an enface ventricular view of the complete MV apparatus, imaging with 3D echocardiography can overcome this limitation, and 3D-guided measurement of the MVA has been found to be more accurate than 2D-guided measurements. Additionally, quantitation of MR severity has been reported to be more accurate with 3D echocardiography because of the lack of geometric assumptions such as regurgitant orifice shape used to quantify MR severity with 2D methods. 10 
MV Pathology
The usefulness of 3D TEE in localizing the site of MR and providing accurate assessment of the wide spectrum of degenerative MV disease is well established and will not FIGURE 2. A, Three-dimensional mitral valve left atrial (LA) view demonstrating schematic of perpendicular orientation of the clip arms (blue lines) relative to the curvilinear relationship of the anterior and posterior leaflets from medial to lateral (curved double-headed red arrow with the arrowheads pointing to the medial and lateral commissures); yellow arrow points to flail P2. Asterisk marks the interatrial septum (IAS). I ¼ inferior; LAA ¼ left atrial appendage; S ¼ superior. B, Left atrial view of a large flail P3 segment. The double-headed red arrow points to 2 ruptured chordae tendinea. Asterisk marks the IAS. C, Two-dimensional orthogonal planes demonstrating the Brockenbrough transseptal needle (red arrow) in only one plane. The yellow arrow points to fossa ovalis in the anteroposterior plane, and the green arrowheads point to the aortic root. RA ¼ right atrium. D, Three-dimensional zoom dual-layout RA and LA views of fossa ovalis (red arrowheads) in relation to the superior vena cava (SVC), inferior vena cava (IVC), and aortic root. The eustachian ridge is marked by a green asterisk. The coronary sinus is seen in cross section (green arrow). The white arrow points to the mitral valve. E-F, Orthogonal atrial septum planes (E) and corresponding full-volume view (F). White arrow points to the aortic root. Red arrow points to the Mullen assembly. be reviewed here. 11 Percutaneous MV repair involves grasping the free edges of the anterior and posterior leaflets at the site of MR. Cleft-like deep indentations in the posterior leaflet at the site of minor commissures may preclude successful PMVR when associated with significant MR. Three-dimensional TEE is superior to 2D TEE in detecting mitral clefts 2, 11 that can be viewed from the atrial and ventricular surface of the MV (Figure 1 Multibeat (typically 6 beats) full-volume acquisition (4-dimensional [4D] mode ultrasound systems; General Electric Healthcare and Siemens Medical Solutions, Inc) is usually necessary to obtain optimal 3D color flow Doppler (CFD) imaging of the entire LA or LV surface of the MV at an adequate frame rate (at least 10 volumes per second). Single-beat real-time high-volume-rate fullvolume (4D mode General Electric Healthcare and Siemens Medical Solutions, Inc) CFD can be useful in patients with irregular heart rhythm or intraprocedurally when time to obtain 3D CFD is limited and realtime imaging is preferred. 
Atrial Septum
The first step in PMVR is the transseptal puncture (TSP). Two-dimensional TEE provides a tomographic "thin-slice" view of the atrial septum that may limit simultaneous visualization of the transseptal needle tip in 2 orthogonal planes that provide the necessary anterioposterior (midesophageal aortic valve short-axis view) and superior-inferior (midesophageal bicaval view) coordinates, a prerequisite for accurate guidance of the TSP (Figure 2 
E and F; Video 2, E and F) mode provides real-time visualization of the entire atrial septum in a single-image acquisition that is obtained from the 2D bicaval view. 13 All 3D/4D zoom acquisition modes allow for the display of the right and left atrial surfaces of the fossa ovalis and atrial septum simultaneously side-byside (Figure 2, D) . Unlike the highly mobile MV, the atrial septum is rather stationary and adequate live 3D (full-volume or 3D/ 4D zoom) spatial (detail) resolution can be achieved despite a low frame rate. 13 Left Atrial Appendage and Left Superior Pulmonary Vein Important LA anatomic landmarks during procedural guidance include the LA appendage (LAA), left superior (upper) pulmonary vein (LSPV) ostia, and both the free wall and dome of the LA because the LSPV serves as a wire anchor, and instrumentation of the LA by stiff wires and bulky catheters can perforate the LA or its thin-walled appendage. Imaging of the atrial septum and LA in 3D TEE is best achieved from the bicaval 2D window. We prefer the single-beat real-time full-volume mode to 3D zoom because it minimizes the number of steps needed to achieve the desired image during intraprocedural guidance due to the need for rapid switching from 3D to 2D and vice versa. A full volume of the atrial septum is first optimized (Figure 2 , E and F; Video 2, E and F) by using the lateral width button to include most of the superior and inferior septal rims. Enface view of the MV and its adjacent structures including the atrial septum and aortic valve is then 
]) to crop out additional noise artifacts are used to enhance 3D image quality, keeping in mind that optimal 3D images require optimal 2D images.
ROLE OF 3D TEE DURING INTRA-PROCEDURAL GUIDANCE
The role of 3D TEE during intraprocedural guidance entails thorough knowledge of all types of catheters/sheaths/wires and dilators that are used during the procedure because each may have a unique 3D "fingerprint." Blooming artifacts may make it very difficult to distinguish between wires and catheters, however. In the order deployed, these include:
1. 8F Mullen sheath and dilator 2. Brockenbrough needle 3. 0.032-inch Amplatz; J-tip extra-stiff wire to be anchored in the LSPV (optional) 4. 0.035-inch Amplatz; super-stiff J-tip wire to be anchored in the LSPV 5. Inoue dilator (optional) 6. 4F multipurpose catheter for LA pressure monitoring (optional) 7. Steerable guide catheter (SGC) with its dilator 8. Clip delivery system (CDS) with MitraClip device
The actual procedure is divided into 7 main steps (adapted from Wunderlich and Siegel 2 ). Herein, we provide a step-by-step 3D TEE guide for each of the sequential procedural steps.
Step 1: Transseptal Puncture The TSP site represents one of the most important aspects of the MitraClip procedure. Three-dimensional TEE may be a useful adjunctive imaging modality to guide the TSP when the transseptal needle is not well seen (Figure 4 , F-G; Video 4, F-I). When the desired puncture site is very posterior, visualization may be difficult by 2D TEE, (Figure 6 , C; Video 6, C). Three-dimensional TEE is an invaluable tool to guide all these steps from a single window and without the need for excessive probe manipulation.
As pointed out by Wunderlich and Siegel, 2 unsuitable sites for transseptal access include patent foramen ovale because of its far anterior location and atrial septal defects because the MitraClip delivery sheath cannot be stabilized in the defect and there is increased risk of atrial septal tear.
Step 2: Advancing the SGC Sheath Into the LA The SGC is a large (24F) sheath with its own dilator through which the CDS is advanced into the LA. On 3D imaging, it may appear as a tubular structure with a clear center that is flanked by 2 linear rail-like dense echoes (Figure 6, D; Video 6, D) , and an echobright radiopaque double ring characterizes its tip ( Figure 6 , C and E-F; Video 6, C and E-F). The SGC is advanced into the LA over the Amplatz super-stiff wire that was anchored in the LSPV (see Figure 5 , G). Advancement of the SGC within the LA can be continuously monitored using 3D TEE, and the distance of the SGC tip from the septum can be quantified (Figures 6, E and F and 7, A and B; Videos 6, E and F and 7, A and B). This step avoids inadvertent puncturing of the LA free wall. After the SGC is safely placed in the LA, its dilator is retrieved first, followed by the Amplatz super-stiff wire.
Step 3: Advancing the CDS Into the LA The MitraClip device consists of 2 arms and 2 grippers used to grasp the opposing free edges of the anterior and posterior leaflet and is readily seen on 3D TEE (Figure 7 , C; Video 7, C). Both arms and grippers are covered with polyester fabric to enhance endothelialization. The CDS is advanced into the LA through the SGC under continuous fluoroscopic and TEE guidance (Figure 7 , D; Video 7, D). It is necessary during this step to ensure that the tip of the SGC remains across the atrial septum (see Figure 6 , E and F; Video 6, E and F) and to continuously track the CDS as it is advanced within the LA to ensure that it remains away from the LA free wall (see Figure 7 , A; Video 7, A) and LAA. Whereas with 2D TEE this step requires multiple views in different planes and multiple probe manipulations, with 3D TEE enface imaging permits visualization and tracking of the SGC and CDS within the LA. The MitraClip can be seen in real time as it advances through and exits the SGC.
Step 4: Steering and Positioning of the MitraClip Above the MV In order to position the CDS above the MV, the SGC is angled down toward the mitral leaflets using several maneuvers (Figure 7 , E; Video 7, E). Instead of the frequent probe manipulations and multiple views necessary with 2D TEE guidance during this step, real-time live 3D imaging using either full volume or 3D zoom with wide-angle acquisition can greatly facilitate this part of the procedure because it provides an intuitive enface view (surgeon view) of the mitral leaflets and approaching clip. Assuring perpendicularity of the open arms of the advancing MitraClip to the line of malcoaptation is of paramount importance and is particularly challenging with 2D but relatively easy with 3D imaging regardless of whether the MR is central, paracentral, or paracommissural (see Figure 2 , A and B; Video 2, A and B). Enface 3D CFD imaging from the LA and LV surfaces of the MV using appropriate filter settings can assist in localizing the jet origin, thus facilitating proper alignment of the clip arms. Threedimensional imaging can guide medial/ lateral, anterior/posterior repositioning and clockwise or counterclockwise rotation of the MitraClip as it is being advanced toward the plane of the MV (Figure 7 , G and H; Video 7, G and H). Live 3D imaging is also invaluable in guiding placement of additional clips when necessary.
Step 5 Step 6: Pullback From the LV Toward the LA and Grasping of the MV Leaflets This step remains exclusively 2D TEE guided with no role for 3D TEE except when proper orientation of the clip arms is in question as noted in step 5.
Step 7: Assessment of the Result After MitraClip Deployment Adequacy of tissue grasp is best judged by 2D imaging of the partially closed clip. Leaflet tissue must be seen between the clip arms and the grippers. The LV outflow tract view typically provides the best visualization of leaflet insertion into the device. Restricted motion of both leaflets must be seen as well, to indicate approximation of leaflet edges by the clip. After the full closure of the MitraClip, it is necessary to assess the morphologic features of the valve and to determine the severity of residual regurgitation and stenosis. Three-dimensional TEE CFD can assess the origin of residual MR and help determine the need for additional clips (Figure 8 , A-C; Video 8, A-C).
Final orifice size and geometry can be evaluated best in either full-volume or 3D zoom formats. The MV should be imaged enface from both the LA (Figure 8 (Figure 8, F) . The residual mitral orifice(s) area(s) can be measured planimetrically using the 3D software.
Three-dimensional TEE can also help guide withdrawal of the CDS from the LA and across the atrial septum after clip deployment. Iatrogenic atrial septal defect is a well-known consequence of PMVR because of the large size of the SGC. The shape and dimensions of the defect can be readily assessed on 3D TEE, and if percutaneous closure of the iatrogenic atrial septal defect is deemed necessary, 3D TEE can guide its closure. 14, 15 LIMITATIONS AND FUTURE DEVELOPMENTS Compared with 2D imaging, 3D imaging has lower temporal and spatial or detail resolution that preclude it from being the only imaging modality used for the procedure. 4, 13 Performance of the MitraClip procedure under 3D TEE guidance requires excellent 3D imaging skills, and multibeat full-volume 3D imaging requires electrocardiographic gating, no arrhythmias, and breath hold and therefore may be associated with stich artifacts. 13 Leaflet grasping is a procedural step that still is performed solely by 2D TEE. Future advances in 3D imaging technology, and the use of vena contracta and color jet evaluation, will enhance its use during the procedure and will potentially simplify, facilitate, and optimize procedure guidance. The development of fusion imaging that allows superimposition of the 2D or 3D echocardiographic image to the fluoroscopic image in real time may allow for safer and more efficient catheter movement.
SUMMARY
Recent innovations and advancements in 3D echocardiography allow for better understanding of anatomic relationships and improve communication with the interventional cardiologist for guidance of catheterbased interventions. Three-dimensional TEE plays a critical role in both planning and guiding the MitraClip procedure. The intuitive display of the LA and mitral leaflets reduces procedure time and increases accuracy of device positioning. Threedimensional imaging of the atrial septum may facilitate selection of TSP site (see Figure 4 , F-I and 5, C; Video 4, F-I and 5, C).
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